Guardion Health Sciences, Inc. Announces Proposed Public Offering
HOUSTON, TEXAS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition...
Day: February 17, 2022
Suggestion Box, Inc. (OTC:SGTB) Submits for Corporation Name Provides Shareholder Updates
Prepares for Upcoming Merger and Plans for FINRA Name and Symbol ChangeLas Vegas, Nevada, Feb. 17, 2022 (GLOBE NEWSWIRE) --...
Streamline Health® Announces Strategic Organizational Improvements to Accelerate Growth
Ben Stilwill promoted to President & CEO, eValuator Solutions; Amy Sebero appointed Chief Growth Officer, eValuator Solutions, bringing 40 years...
Antares Pharma To Report Fourth Quarter And Full-Year 2021 Financial And Operating Results
EWING, N.J., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today...
180 Life Sciences Corp. Forms Scientific Advisory Board
PALO ALTO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...
Vaxcyte to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022
SAN CARLOS, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines...
Veru Announces the Presentation of Updated Data from the Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2022 ASCO Genitourinary Cancers Symposium
MIAMI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing...
Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring
BOSTON, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development...
POINT Biopharma to Participate in Upcoming Virtual Investor Conferences
INDIANAPOLIS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating...
Assure Appoints Brian McDonald as Vice President of Business Operations
DENVER, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative...
Entera Bio to Present at Aegis Virtual Conference on February 23rd
BOSTON and JERUSALEM, Israel, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development...
AREV Life Sciences Advances Developments, New Appointments and Relationships
VANCOUVER, British Columbia , Feb. 17, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – AREV Life Sciences Global Corp. (CSE: AREV)...
Celsion Reports Data Safety Monitoring Board Unanimous Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer
OVATION 2 Study is Over 75% Enrolled; Full Enrollment Expected by Mid-2022 Novel Gene-Mediated Immunotherapy is Safe and Demonstrates an Acceptable Risk/Benefit When Administered Over a Six-Month Period LAWRENCEVILLE, N.J.,...
GIMOTI® Commercialization Update
New Research Study Demonstrates Increased Acceptance Among Healthcare Providers Patient Testimonial Videos Detail Benefits Included and Available on GimotiRx.com Expanded...
Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies
Collaboration Enables Further Expansion of Mass Cytometry in the Middle EastSOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) --...
Catalyst Pharmaceuticals to Launch LEMS Aware Podcast on Rare Disease Day 2022
Initiative Part of Expansion of Education and Awareness Activities for Lambert-Eaton Myasthenic Syndrome CommunityCORAL GABLES, Fla., Feb. 17, 2022 (GLOBE...
Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational 2022 Virtual Conference
HOUSTON, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines...
Alimera Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022, and Provide Corporate Update
Conference Call to be held Thursday, February 24, 2022, at 9:00am Eastern TimeATLANTA, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Alimera...
Sight Sciences Launches “Don’t Wait for Too Late” Awareness Campaign for Glaucoma
Educational campaign aims to raise awareness among the optometric community of minimally invasive glaucoma surgery (MIGS) as an earlier surgical...
Arvinas PROTAC® Protein Degrader Bavdegalutamide (ARV-110) Continues to Demonstrate Clinical Benefit in Men with Metastatic Castration-Resistant Prostate Cancer
– Bavdegalutamide treatment demonstrated robust activity in molecularly defined tumors (androgen receptor T878X/H875Y), with a 46% PSA50 rate and durable...
